Page last updated: 2024-09-03

ginsenoside rh2 and angiotensin ii

ginsenoside rh2 has been researched along with angiotensin ii in 1 studies

Compound Research Comparison

Studies
(ginsenoside rh2)
Trials
(ginsenoside rh2)
Recent Studies (post-2010)
(ginsenoside rh2)
Studies
(angiotensin ii)
Trials
(angiotensin ii)
Recent Studies (post-2010) (angiotensin ii)
295120038,1521,0897,413

Protein Interaction Comparison

ProteinTaxonomyginsenoside rh2 (IC50)angiotensin ii (IC50)
Atrial natriuretic peptide receptor 3Homo sapiens (human)0.002
Type-1A angiotensin II receptor Rattus norvegicus (Norway rat)0.002
Type-1B angiotensin II receptorRattus norvegicus (Norway rat)0.0018
Type-1 angiotensin II receptorHomo sapiens (human)0.0055
Type-2 angiotensin II receptorRattus norvegicus (Norway rat)0.004
Type-2 angiotensin II receptorHomo sapiens (human)0.0011

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Han, X; Liang, G; Luo, W; Tu, Y; Wang, M; Wang, Q; Wang, Y; Xu, J; Yu, T1

Other Studies

1 other study(ies) available for ginsenoside rh2 and angiotensin ii

ArticleYear
20(S)-ginsenoside Rh2 inhibits angiotensin-2 mediated cardiac remodeling and inflammation associated with suppression of the JNK/AP-1 pathway.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2023, Dec-31, Volume: 169

    Topics: Angiotensin II; Animals; Heart Failure; Hypertension; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Transcription Factor AP-1; Ventricular Remodeling

2023